earnings
PH
NASDAQ · PHAR
Pharming Group N.V.
Healthcare · Biotechnology
$12.93
Down-$0.24 (-1.82%)
Updated Nov 4, 2026, 7:09 PM
SID Score
4.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.2B
- P/E ratio
- 3,147.1
- Dividend yield
- 0.00%
- 52-week range
- $9.11 – $18.41
- Volume
- 21.64K
- Avg. volume
- 16.7K
Price performance · PHAR
PHAR price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
PHAR closed at $12.93 after 21 trading sessions, up 33.57% for the selected period.
- Last close
- $12.93
- Period change
- +33.57%
- Period low
- $9.11
- Period high
- $12.93
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $12.69 | $13.00 | $12.45 | $12.93 | 21.64K |
| Nov 2, 2026 | $12.75 | $12.75 | $12.455 | $12.73 | 19.96K |
| Oct 30, 2026 | $12.20 | $12.31 | $12.09 | $12.23 | 14.05K |
| Oct 29, 2026 | $12.25 | $12.27 | $11.75 | $12.13 | 12.42K |
| Oct 28, 2026 | $11.85 | $12.28 | $11.85 | $12.26 | 29.03K |
| Oct 27, 2026 | $12.01 | $12.1899 | $11.7646 | $11.87 | 19.19K |
| Oct 26, 2026 | $11.55 | $11.92 | $11.55 | $11.90 | 43.47K |
| Oct 23, 2026 | $11.32 | $11.45 | $10.76 | $11.20 | 25.78K |
| Oct 22, 2026 | $10.57 | $10.80 | $10.55 | $10.67 | 21.6K |
| Oct 21, 2026 | $9.47 | $9.73 | $9.45 | $9.65 | 10.92K |
| Oct 20, 2026 | $9.39 | $9.77 | $9.341 | $9.75 | 6.28K |
| Oct 19, 2026 | $9.315 | $9.34 | $9.11 | $9.11 | 13.37K |
| Oct 16, 2026 | $9.50 | $9.515 | $9.31 | $9.36 | 9.03K |
| Oct 15, 2026 | $9.50 | $10.03 | $9.50 | $9.63 | 7.34K |
| Oct 14, 2026 | $9.55 | $9.64 | $9.49 | $9.64 | 3.96K |
| Oct 13, 2026 | $9.62 | $9.62 | $9.32 | $9.44 | 28.94K |
| Oct 12, 2026 | $9.90 | $9.90 | $9.5608 | $9.61 | 7.51K |
| Oct 9, 2026 | $9.79 | $9.85 | $9.5248 | $9.79 | 3.33K |
| Oct 8, 2026 | $9.65 | $9.7716 | $9.4413 | $9.53 | 5.12K |
| Oct 7, 2026 | $9.65 | $9.75 | $9.59 | $9.65 | 3.83K |
| Oct 6, 2026 | $9.86 | $9.86 | $9.68 | $9.68 | 6.73K |
Latest PHAR news
The latest Smart Investors Daily articles mentioning PHAR.
Stock researchResearch & News · Competitors
Company
Market Activity
Research & News
Loading stock research…

